Telix Pharmaceuticals Ltd.
http://www.telixpharma.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Telix Pharmaceuticals Ltd.
The IPO Queue Fills Up, But A Recovery Is A Way Off
Six biopharma companies have filed to list their shares on US exchanges so far this year, but the sums they are seeking are small.
IPOs Collapse In The Second Quarter
Biotechs have had a difficult time raising cash through flotations over the past quarter, with one stepping away altogether.
Finance Watch: Alumis Launches IPO In Market Less Receptive Than Expected
Public Company Edition: Alumis grosses $250m after it planned to raise up to $317.7m in its IPO. Also, Zealand adds $1bn in a post-data offering, Tectonic and Eliem close $130.7m and $120m private placements to support recent mergers, and Ginkgo cuts 35% of its workforce.
Telix Scuttles Its US Listing
The radiopharmaceutical developer abandoned its NASDAQ IPO at the eleventh hour. What now?
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice